Zobrazeno 1 - 10
of 269
pro vyhledávání: '"Eugene D Kwon"'
Autor:
Mohamed E. Ahmed, Ahmed M. Mahmoud, Guiseppe Reitano, Wael Zeina, Kelly Lehner, Carter A. Day, Irbaz Riaz, Daniel S. Childs, Jacob J. Orme, A. Tuba Kendi, Geoffrey B. Johnson, R. Jeffrey Karnes, Eugene D. Kwon, Jack R. Andrews
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 38-45 (2024)
Background and objective: Visceral metastatic disease in prostate cancer patients conveys a poor prognosis. Using advanced imaging techniques, studies have demonstrated increasing detection rates of visceral metastasis. Visceral metastases are now se
Externí odkaz:
https://doaj.org/article/8d4eb652bd404f21a76df8cc20d2d208
Autor:
Ahmed M. Mahmoud, Mohamed E. Ahmed, A. Tuba Kendi, Matthew Thorpe, Geoffrey B. Johnson, Irbaz Bin Riaz, Jacob J. Orme, Eugene D. Kwon, Jack R. Andrews, Daniel S. Childs
Publikováno v:
BJUI Compass, Vol 5, Iss 2, Pp 319-324 (2024)
Abstract Background For men with prostate cancer, radiographic progression may occur without a concordant rise in prostate‐specific antigen (PSA). Our study aimed to assess the prevalence of radiographic progression using C‐11 choline positron em
Externí odkaz:
https://doaj.org/article/29b24f73a0de43fead3611b2e5a728e1
Autor:
Kamran Ali Ahmed, Brandon M Barney, Brian James Davis, Sean S Park, Eugene D Kwon, Kenneth R Olivier
Publikováno v:
Frontiers in Oncology, Vol 2 (2013)
Purpose/Objective(s): To report outcomes and toxicity for patients with oligometastatic (≤5 lesions) prostate cancer (PCa) treated with stereotactic body radiotherapy (SBRT).Materials/Methods: Seventeen men with 21 PCa lesions were treated with SBR
Externí odkaz:
https://doaj.org/article/b9c7792d954d47a098113d6220adf0e4
Autor:
Mohamed E. Ahmed, MB, BCh, Jack R. Andrews, MD, Vidhu B. Joshi, BSc, Lance A. Mynderse, MD, Matthew K. Tollefson, MD, R. Jeffrey Karnes, MD, Eugene D. Kwon, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 3, Pp 689-692 (2021)
Externí odkaz:
https://doaj.org/article/33f61aaabfef4771a630b1ea6047eb77
Autor:
Jack R. Andrews, MD, Mohamed E. Ahmed, MB, BCh, Giovanni Motterle, MD, Sam T. Albadri, MD, Rimki Haloi, R. Jeffrey Karnes, MD, Eugene D. Kwon, MD, Katharine A. Price, MD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 5, Pp 601-607 (2020)
A 62-year-old man presented with a rising serum concentration of prostate-specific antigen (PSA) to 53.3 ng/mL (to convert to μg/L, multiply by 1) and a PSA doubling time of 2.6 months. Computed tomography, fluorodeoxyglucose–positron emission tom
Externí odkaz:
https://doaj.org/article/e468b8e564154f18ae32bee0244823cf
Autor:
Jeanette E. Eckel‐Passow, Thai H. Ho, Daniel J. Serie, John C. Cheville, R. Houston Thompson, Brian A. Costello, Haidong Dong, Eugene D. Kwon, Bradley C. Leibovich, Alexander S. Parker
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 1152-1160 (2020)
Abstract Objectives Previous studies noted discordance of programmed death‐1 (PD‐1) and one of its ligands (PD‐L1) across patient‐matched primary and metastatic clear cell renal cell carcinoma (ccRCC). There are inconsistencies if the primary
Externí odkaz:
https://doaj.org/article/c15982ee97dd45c59bb125bac0dcdb50
Autor:
Krishan R. Jethwa, MD, Christopher D. Hellekson, MD, Jaden D. Evans, MD, William S. Harmsen, MS, Tyler J. Wilhite, MD, Thomas J. Whitaker, PhD, Sean S. Park, MD PhD, C. Richard Choo, MD, Bradley J. Stish, MD, Kenneth R. Olivier, MD, Rimki Haloi, MBBS, Val J. Lowe, MD, Brian T. Welch, MD, J. Fernando Quevedo, MD, Lance A. Mynderse, MD, R.Jeffrey Karnes, MD, Eugene D. Kwon, MD, Brian J. Davis, MD PhD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 4, Pp 659-667 (2019)
Purpose: To assess gastrointestinal (GI) and genitourinary (GU) adverse events (AEs) of 11C-choline-positron emission tomography (CholPET) guided lymph node (LN) radiation therapy (RT) in patients who experience biochemical failure after radical pros
Externí odkaz:
https://doaj.org/article/8e07834416a34d0eba5035d62d782358
Autor:
Robert W. Gao, BS, Kenneth R. Olivier, MD, Sean S. Park, MD, PhD, Brian J. Davis, MD, PhD, Thomas M. Pisansky, MD, Richard Choo, MD, Eugene D. Kwon, MD, R. Jeffrey Karnes, MD, William S. Harmsen, MS, Bradley J. Stish, MD
Publikováno v:
Advances in Radiation Oncology, Vol 4, Iss 2, Pp 314-322 (2019)
Purpose: This study aimed to compare outcomes of patients with prostate cancer with bone metastases treated with stereotactic body radiation therapy (SBRT) versus conventionally fractionated radiation therapy (CFRT). Methods and materials: An institu
Externí odkaz:
https://doaj.org/article/b17ba1bc1e814446ba90aa29e72e224c
Publikováno v:
Expert Review of Anticancer Therapy. 23:177-185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a2c6c70696dd40efd04eab206a7d87c
https://doi.org/10.1080/14737140.2023.2173174
https://doi.org/10.1080/14737140.2023.2173174
Autor:
Fabrice Lucien, Yohan Kim, Jing Qian, Jacob J. Orme, Henan Zhang, Ali Arafa, Feven Abraha, Ishwor Thapa, Erik J. Tryggestad, William S. Harmsen, Jorgena Kosti, Hesham Ali, Val J. Lowe, Geoff B. Johnson, Eugene D. Kwon, Haidong Dong, Sean S. Park
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:725-737
SABR has demonstrated clinical benefit in oligometastatic prostate cancer. However, the risk of developing new distant metastatic lesions remains high, and only a minority of patients experience durable progression-free response. Therefore, there is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f96eba1b2e6b78fdda0250afe2f00df
https://doi.org/10.1016/j.ijrobp.2022.05.037
https://doi.org/10.1016/j.ijrobp.2022.05.037